Compounds and compositions for treating conditions associated with cGAS
US12404261B2 · kind B2 · utility
0Cited by
1References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 20, 2021 |
| Grant date | Sep 2, 2025 |
| Priority date | — |
| Expiry date | Dec 20, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/107
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to a compound of Formula (I): or a pharmaceutically acceptable salt, hydrate, solvate, stereoisomer, or tautomer thereof, wherein R1 through R8 are as defined herein, and methods of making and using the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.